Journal Information
Vol. 46. Issue 6.
Pages 335-336 (June 2010)
Vol. 46. Issue 6.
Pages 335-336 (June 2010)
Letter to the Editor
Full text access
Flu Pandemic Consequences in Spain Might Be Minimized With Conjugate Anti-Pneumococcal Vaccine
¿Se podrían minimizar los efectos de la pandemia por gripe A (H1N1) en España con la vacuna antineumocócica conjugada?
Visits
3997
a Área de Pediatría, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
b Grupo Gallego de Genética, Vacunas e Investigación Pediátrica, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain
c Red Gallega de Investigación Pediátrica, Santiago de Compostela, Spain
d Departamento de Pediatría, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
K.P. Klugman, S.A. Madhi.
Pneumococcal vaccines and flu preparedness.
Science, 316 (2007), pp. 49-50
[2.]
Centers for Disease Control and Prevention (CDC).
Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection-United States, April-August 2009.
MMWR Morb Mortal Wkly Rep, 58 (2009), pp. 941-947
[3.]
Centres for Disease Control and Prevention (CDC).
Bacterial coinfections in lung tissue specimesn from fatal cases of 2009 pandemic influenza A (H1N1)–United States May–August 2009.
MMWR, 58 (2009), pp. 1071-1074
[4.]
A. Kumar, R. Zarychanski, R. Pinto, D.J. Cook, J. Marshall, J. Lacroix, et al.
Critically ill patients with 2009 influenza A (H1N1) infection in Canada.
JAMA, 302 (2009), pp. 1872-1879
[5.]
The ANZIC Influenza Investigators.
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand.
N Engl J Med, 361 (2009), pp. 1925-1934
[6.]
A. Delgado, F. Martinón-Torres, et al.
Enfermedad Neumocócica.
Manual de Vacunas en Pediatría 2008, 4th ed., pp. 392-406
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica